Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.9 (
glucose-6-phosphatase
)
3,081
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The kinetics of rat liver
glucose-6-phosphatase
(
EC 3.1.3.9
) were studied in intact and detergent-disrupted microsomes from normal and diabetic rats at pH 7.0 using two buffer systems (50 mM Tris-cacodylate and 50 mM 4-(
2-hydroxyethyl
)-1-piperazineethanesulfonic acid) and glucose-6-P varied from 20 microM to 10 mM. Identical data were obtained when the phosphohydrolase activity was quantified by a colorimetric determination of Pi or by measuring 32Pi formed during incubations with [32P]glucose-6-P. In every instance the initial rate data displayed excellent concordance with that expected for a reaction obeying Michaelis-Menten kinetics. The present findings agree with recently reported results of Traxinger and Nordlie (Traxinger, R. R., and Nordlie, R. C. 1987) J. Biol. Chem. 262, 10015-10019) that
glucose-6-phosphatase
activity in intact microsomes exhibits hyperbolic kinetics at concentrations of glucose-6-P above 133 microM, but fail to confirm their finding of sigmoid kinetics at substrate concentrations below 133 microM. We conclude that glucose-6-P hydrolysis conforms to a hyperbolic function at concentrations of glucose-6-P existing in livers of normal and diabetic rats in vivo.
...
PMID:The glucose-6-phosphatase system in rat hepatic microsomes displays hyperbolic kinetics at physiological glucose 6-phosphate concentrations. 283 85